Calithera Biosciences PE Ratio 2013-2020 | CALA

Current and historical p/e ratio for Calithera Biosciences (CALA) from 2013 to 2020. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Calithera Biosciences PE ratio as of November 23, 2020 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Calithera Biosciences PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2020-11-23 4.96 0.00
2020-09-30 3.45 $-1.38 0.00
2020-06-30 5.28 $-1.44 0.00
2020-03-31 4.44 $-1.73 0.00
2019-12-31 5.71 $-1.96 0.00
2019-09-30 3.09 $-2.08 0.00
2019-06-30 3.90 $-2.22 0.00
2019-03-31 6.74 $-1.73 0.00
2018-12-31 4.01 $-1.49 0.00
2018-09-30 5.25 $-1.29 0.00
2018-06-30 5.00 $-0.94 0.00
2018-03-31 6.30 $-1.00 0.00
2017-12-31 8.35 $-0.85 0.00
2017-09-30 15.75 $-0.99 0.00
2017-06-30 14.85 $-1.26 0.00
2017-03-31 11.55 $-1.66 0.00
2016-12-31 3.25 $-1.96 0.00
2016-09-30 3.25 $-1.95 0.00
2016-06-30 3.71 $-2.00 0.00
2016-03-31 5.68 $-1.89 0.00
2015-12-31 7.66 $-1.81 0.00
2015-09-30 5.43 $-1.76 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.345B $0.022B
Calithera Biosciences, Inc. is a clinical-stage pharmaceutical company. It is focused on discovering and developing small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer. The Company's lead product candidate includes CB-839 which is in three Phase I clinical trials for the treatment of patients with solid tumors, leukemias, lymphomas, and multiple myeloma. Calithera Biosciences, Inc. is headquartered in South San Francisco, California.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $78.990B 43.06
Takeda Pharmaceutical (TAK) Japan $55.331B 10.32
Astellas Pharma (ALPMY) Japan $28.523B 17.81
Eisai (ESALY) Japan $22.272B 19.41
UCB SA (UCBJF) Belgium $21.755B 0.00
Merck (MKGAF) Germany $19.910B 26.11
Catalent (CTLT) United States $17.018B 50.90
Grifols, S.A (GRFS) Spain $12.947B 14.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.467B 0.00
IPSEN SA ADR (IPSEY) France $8.365B 0.00
Neurocrine Biosciences (NBIX) United States $8.315B 65.44
Jazz Pharmaceuticals (JAZZ) Ireland $7.973B 12.88
Arrowhead Pharmaceuticals (ARWR) United States $7.038B 0.00
STADA ARZNEIMI (STDAF) Germany $6.884B 0.00
Ionis Pharmaceuticals (IONS) United States $6.871B 67.32
Orion OYJ (ORINY) Finland $6.272B 21.76
United Therapeutics (UTHR) United States $6.045B 12.87
Evotec AG (EVTCY) Germany $4.821B 327.61
PTC Therapeutics (PTCT) United States $4.308B 0.00
Sage Therapeutics (SAGE) United States $3.965B 0.00
ChemoCentryx (CCXI) United States $3.880B 0.00
FibroGen (FGEN) United States $3.686B 0.00
Hypermarcas (HYPMY) Brazil $3.626B 13.34
Nektar Therapeutics (NKTR) United States $3.007B 0.00
Pacira BioSciences (PCRX) United States $2.879B 62.51
Corcept Therapeutics (CORT) United States $2.780B 26.89
Revolution Medicines (RVMD) United States $2.626B 0.00
Cronos Group (CRON) Canada $2.572B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.514B 12.83
Xencor (XNCR) United States $2.354B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.886B 16.14
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.825B 0.00
Trillium Therapeutics (TRIL) Canada $1.749B 0.00
Heron Therapeutics (HRTX) United States $1.674B 0.00
USANA Health Sciences (USNA) United States $1.587B 13.97
Translate Bio (TBIO) United States $1.362B 0.00
Indivior (INVVY) United States $1.291B 16.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.232B 8.56
Endo (ENDP) Ireland $1.198B 1.82
Karyopharm Therapeutics (KPTI) United States $1.149B 0.00
ImmunoGen (IMGN) United States $1.123B 0.00
Zogenix (ZGNX) United States $1.107B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.101B 0.00
Ocular Therapeutix (OCUL) United States $1.047B 0.00
Tilray (TLRY) Canada $0.983B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.942B 0.00
Vectura Group (VEGPF) United Kingdom $0.925B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.875B 544.63
Calliditas Therapeutics AB (CALT) Sweden $0.791B 0.00
Esperion Therapeutics (ESPR) United States $0.775B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.765B 0.00
Radius Health (RDUS) United States $0.735B 0.00
VAXART, INC (VXRT) United States $0.701B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.650B 33.89
Collegium Pharmaceutical (COLL) United States $0.641B 37.84
Spectrum Pharmaceuticals (SPPI) United States $0.630B 0.00
Chinook Therapeutics (KDNY) United States $0.589B 0.00
Siga Technologies (SIGA) United States $0.567B 15.91
Aerie Pharmaceuticals (AERI) United States $0.564B 0.00
Flexion Therapeutics (FLXN) United States $0.560B 0.00
Organogenesis Holdings (ORGO) United States $0.548B 0.00
Ardelyx (ARDX) United States $0.510B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.465B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.450B 0.00
Molecular Templates (MTEM) United States $0.450B 0.00
Akebia Therapeutics (AKBA) United States $0.416B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.405B 0.00
Innate Pharma SA (IPHYF) France $0.396B 0.00
TherapeuticsMD (TXMD) United States $0.376B 0.00
Harpoon Therapeutics (HARP) United States $0.371B 0.00
Profound Medical (PROF) Canada $0.361B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.347B 9.05
DURECT (DRRX) United States $0.345B 0.00
Redhill Biopharma (RDHL) Israel $0.337B 0.00
KalVista Pharmaceuticals (KALV) United States $0.336B 0.00
Concert Pharmaceuticals (CNCE) United States $0.329B 0.00
Rafael Holdings (RFL) United States $0.324B 0.00
MEI Pharma (MEIP) United States $0.317B 0.00
Altimmune (ALT) United States $0.308B 0.00
Summit Therapeutics (SMMT) United States $0.296B 0.00
Menlo Therapeutics (VYNE) United States $0.280B 0.00
Jounce Therapeutics (JNCE) United States $0.277B 0.00
CASI Pharmaceuticals (CASI) United States $0.274B 0.00
CTI BioPharma (CTIC) United States $0.274B 0.00
OptiNose (OPTN) United States $0.259B 0.00
Lannett Co Inc (LCI) United States $0.254B 6.69
Nature's Sunshine Products (NATR) United States $0.241B 15.51
IMV INC (IMV) Canada $0.232B 0.00
Aquestive Therapeutics (AQST) United States $0.227B 0.00
Xeris Pharmaceuticals (XERS) United States $0.221B 0.00
Otonomy (OTIC) United States $0.208B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.208B 0.00
Alpine Immune Sciences (ALPN) United States $0.186B 0.00
Champions Oncology (CSBR) United States $0.169B 0.00
Heat Biologics (HTBX) United States $0.161B 0.00
Taiwan Liposome (TLC) Taiwan $0.161B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.138B 0.00
Infinity Pharmaceuticals (INFI) United States $0.137B 0.00
Aclaris Therapeutics (ACRS) United States $0.133B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.132B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.124B 0.00
MediWound (MDWD) Israel $0.103B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.102B 0.00
Lipocine (LPCN) United States $0.097B 0.00
ProPhase Labs (PRPH) United States $0.086B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.080B 0.00
Biomerica (BMRA) United States $0.080B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.079B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.073B 0.00
Nutriband (NTRB) United States $0.071B 0.00
ElectroCore (ECOR) United States $0.070B 0.00
Novan (NOVN) United States $0.068B 0.00
SCYNEXIS (SCYX) United States $0.067B 0.00
Natural Alternatives (NAII) United States $0.066B 127.63
Addex Therapeutics (ADXN) Switzerland $0.066B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.064B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.064B 0.00
KemPharm (KMPH) United States $0.063B 0.00
GTx (ONCT) United States $0.062B 0.00
Onconova Therapeutics (ONTX) United States $0.050B 0.00
Forward Pharma (FWP) Denmark $0.047B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.047B 0.00
Recro Pharma (REPH) United States $0.047B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.045B 23.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.041B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.037B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.037B 0.00
PolarityTE (PTE) United States $0.036B 0.00
Mannatechorporated (MTEX) United States $0.033B 4.89
Vical (BBI) United States $0.032B 0.00
Neos Therapeutics (NEOS) United States $0.029B 0.00
Sundial Growers (SNDL) Canada $0.027B 0.00
Regulus Therapeutics (RGLS) United States $0.025B 0.00
Midatech Pharma (MTP) United Kingdom $0.024B 0.00
Iterum Therapeutics (ITRM) Ireland $0.023B 0.00
Hancock Jaffe Laboratories (HJLI) United States $0.018B 0.00
Bio-Path Holdings (BPTH) United States $0.017B 0.00
Jaguar Animal Health (JAGX) United States $0.017B 0.00
Cyanotech (CYAN) United States $0.015B 25.40
Eyegate Pharmaceuticals (EYEG) United States $0.015B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.015B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.014B 0.00
Flex Pharma (SLRX) United States $0.013B 0.00
RXi Pharmaceuticals (PHIO) United States $0.013B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.010B 0.00
China SXT Pharmaceuticals (SXTC) China $0.010B 0.00
Shineco (TYHT) China $0.009B 0.00
JanOne (JAN) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00